Hepatocellular carcinoma (HCC) has been a global health issue and attracted wide attention due to its high incidence and poor outcomes. In this study, our purpose was to explore an effective prognostic marker for HCC. Five cohort profile datasets from GEO (GSE25097, GSE36376, GSE62232, GSE76427 and GSE101685) were integrated with TCGA-LIHC and GTEx dataset to identify differentially expressed genes (DEGs) between normal and cancer tissues in HCC patients, then 5 upregulated differentially expressed genes and 32 downregulated DEGs were identified as common DEGs in total. Next, we systematically explored the relationship between the expression of 37 common DEGs in tumor tissues and overall survival (OS) rate of HCC patients in TCGA and constructed a novel prognostic model composed of five genes (AURKA, PZP, RACGAP1, ACOT12 and LCAT). Furthermore, the predicted performance of the five-gene signature was verified in ICGC and another independent clinical samples cohort, and the results demonstrated that the signature performed well in predicting the OS rate of patients with HCC. What is more, the signature was an independent hazard factor for HCC patients when considering other clinical factors in the three cohorts. Finally, we found the signature was significantly associated with HCC immune microenvironment. In conclusion, the prognostic five-gene signature identified in our present study could efficiently classify patients with HCC into subgroups with low and high risk of longer overall survival time and help clinicians make decisions for individualized treatment.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322700 | PMC |
| http://dx.doi.org/10.3389/fonc.2021.642563 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Integrating traditional machine learning with qPCR validation to identify solid drug targets in pancreatic cancer: a 5-gene signature study.
Front Pharmacol
January 2025
Department of General Surgery, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China.
Background: Pancreatic cancer remains one of the deadliest malignancies, largely due to its late diagnosis and lack of effective therapeutic targets.
Materials And Methods: Using traditional machine learning methods, including random-effects meta-analysis and forward-search optimization, we developed a robust signature validated across 14 publicly available datasets, achieving a summary AUC of 0.99 in training datasets and 0.
Identification of a Novel Mesenchymal Stem Cell-Related Signature for Predicting the Prognosis and Therapeutic Responses of Bladder Cancer.
Stem Cells Int
November 2024
Institute of Urology, Key Laboratory of Gansu Province for Urological Diseases, Gansu Urological Clinical Center, Lanzhou University Second Hospital, Lanzhou 730030, China.
Article Synopsis
- Mesenchymal stem cells (MSCs) show a specific tendency to move towards tumors, impacting cancer growth, treatment resistance, and immune response, prompting research into MSC-related biomarkers for better predicting bladder cancer outcomes.
- This study used data from TCGA and GSE31684 to identify genes linked to MSCs and created a risk assessment model through advanced statistical analysis techniques.
- The final prognostic model highlighted five key genes and classified bladder cancer patients into risk categories, revealing that high MSC-risk patients faced worse outcomes and lower responsiveness to immunotherapy and specific chemotherapy drugs compared to low MSC-risk patients.
Potential shared gene signatures and molecular mechanisms between recurrent pregnancy loss and ovarian cancer.
Front Oncol
November 2024
Gynecology, Women and Children's Hospital of Ningbo University, Ningbo, China.
Article Synopsis
- Ovarian cancer (OV) is a common gynecological cancer, and recurrent pregnancy loss (RPL) is defined as having two or more spontaneous abortions; this study investigates the genetic links between these two conditions.
- Researchers analyzed 71 genes related to RPL and 1,427 genes linked to OV survival, identifying 7 overlapping genes that contribute to both conditions and narrowing them down to a 5-gene prognostic risk model.
- The resulting model predicts OV patient outcomes, shows that low-risk patients may respond better to immunotherapy, and is validated across external cohorts, aiding clinicians in patient management and risk stratification.
Stage-Specific Tumoral Gene Expression Profiles of Black and White Patients with Colon Cancer.
Ann Surg Oncol
February 2025
Department of Surgery, University of Virginia, Charlottesville, VA, USA.
Article Synopsis
- Black patients with colon cancer show more aggressive tumors and treatment resistance compared to white patients, prompting a study on stage-specific genetic differences.
- Analysis of 247 patients revealed 312 genes differ in localized, 105 in regional, and 199 in distant stages, with the IL-17 pathway notably downregulated in localized disease for Black patients.
- Five genes consistently exhibited racial differences across all stages, indicating significant transcriptional disparities in colon cancer that could inform race-specific research and treatment approaches.
Identification of mitophagy-related gene signatures for predicting delayed graft function and renal allograft loss post-kidney transplantation.
Transpl Immunol
December 2024
Department of Kidney Transplantation, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China. Electronic address:
Background: Ischemia-reperfusion injury (IRI) is an unavoidable consequence post-kidney transplantation, which inevitably leads to kidney damage. Numerous studies have demonstrated that mitophagy is implicated in human cancers. However, the function of mitophagy in kidney transplantation remains poorly understood.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!